YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

St. Louis biotech startup raises $105M in funding round

Posted online

St. Louis biotech startup Arch Oncology raised $105 million in a funding round.

The round was led by Eventide Asset Management, Cowen Healthcare Investments and 3x5 Partners.

Arch Oncology is developing biologic therapies to treat patients with tumors and hematologic malignancies.

Read more from the St. Louis Business Journal.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
2024 Most Influential Women

For 25 years, Springfield Business Journal has honored local women for their professional and civic accomplishments and contributions.

Most Read
Update cookies preferences